Open AccessTuberculosis Due to Mycobacterium bovis after Alemtuzumab Administration
Author(s) -
S. Abad,
Emmanuel Gyan,
Laurence Moachon,
Didier Bouscary,
Didier Sicard,
François Dreyfus,
P. Blanche
Publication year - 2003
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/375690
Subject(s) - medicine , mycobacterium bovis , alemtuzumab , tuberculosis , mycobacterium tuberculosis , virology , microbiology and biotechnology , immunology , antibody , pathology , biology
We describe a patient with relapsing B chronic lymphocytic leukemia who developed systemic bacille Calmette-Guérin infection (BCGitis) after administration of alemtuzumab (Campath-1H).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom